Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: Efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the phase III SOLO1 trial Meeting Abstract
| Authors: | Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A.; Gonzalez-Martin, A.; Aghajanian, C.; Bradley, W.; Mathews, C.; Liu, J.; Lowe, E. S.; Bloomfield, R.; DiSilvestro, P. |
| Abstract Title: | Maintenance olaparib after platinum-based chemotherapy in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: Efficacy by the timing of surgery and residual tumour status following upfront or interval cytoreductive surgery in the phase III SOLO1 trial |
| Meeting Title: | 21st International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 29 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Nov 2-5 |
| Meeting Location: | Athens, Greece |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-11-01 |
| Start Page: | A14 |
| End Page: | A15 |
| Language: | English |
| ACCESSION: | WOS:000523502500018 |
| DOI: | 10.1136/ijgc-2019-ESGO.17 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
